Vernal Biosciences

? Time is running out to maximize your #2024budget — and we’ve got the perfect offer to help you make the most of it! ??For a limited time, enjoy up to 25% OFF + FREE SOCKS.??? Get the full details: https://lnkd.in/gRCRZEf7 #mRNA #CDMO #LNP

Exciting new data is available! ?? Join Vernal's Vice President of Business Development, Sourav Mukherjee, PhD and the Charles River Laboratories team in this upcoming webinar to discover how mRNA can revolutionize #antibodymanufacturing—reducing costs and speeding up #clinicalapplications. https://hubs.la/Q02YySz40

Learn new #strategies, explore a compelling #casestudy, and gain actionable insights for your #mRNA work, in this session—packed with scientific value. ?? Christian Cobaugh, Founder and Chief Scientific Officer, presents this webinar ?? and is a expert mRNA resource you can tap into here at Vernal. ?? https://hubs.la/Q02YNnqZ0

Efficiently and confidently assess critical quality attributes (CQAs) throughout every phase of drug development—from discovery to clinical trials. Explore mRNA and LNP Analytical Services available to researchers like you: https://hubs.la/Q02TwX520

A new, 12-month study found that a self-amplifying mRNA COVID-19 vaccine (ARCT-154) works better than the traditional Comirnaty? vaccine. Check out the full press release: https://hubs.la/Q02Tx3ys0

Researchers have developed a flexible #mRNA vaccine that effectively protects mice from deadly Clostridioides difficile (#Cdiff) infections, including recurrent cases. This promising #vaccine could potentially offer a new approach to preventing these challenging and often recurring infections in humans. https://hubs.la/Q02TwkVk0

Don’t miss the opportunity to explore how #mRNA encoded antibodies can streamline production and enhance #patient access to biologics as CRL shares new data from this updated #scientificposter. ?? Register for this upcoming webinar hosted by Charles River Laboratories featuring guest speaker Sourav Mukherjee, PhD, VP of Business Development at Vernal: https://hubs.la/Q02YyQJ00

A Phase I trial of an experimental #mRNA cancer vaccine showed promise for patients with advanced solid #tumors, including lung and melanoma. Interim results indicate the #vaccine can stimulate an immune response and is tolerated, with manageable side effects. Read the full article: https://hubs.la/Q02TwHDT0

?? #mRNAhealthconference attendees—your #mRNA #LNP #CDMO is supposed to ??accelerate your pipeline, ??not slow it down. Vernal is built to push boundaries & deliver results??. ?? Schedule a meeting with Jim Petrilla, Christian Cobaugh & Sourav Mukherjee, PhD & let's make it happen: https://lnkd.in/gjtH2AZw

??Vernal is at the #mRNAHealthConference helping #DrugDevelopers enhance #mRNA efficacy, cut costs & streamline #clinicaltrial feasibility. Schedule a meeting with Jim Petrilla, Christian Cobaugh & Sourav Mukherjee, PhD—your future self will thank you! ?? https://lnkd.in/gjtH2AZw